Publications by authors named "Helene Favre"

Claim this Profile
I
Implementation of an in situ simulation-based training adapted from Morbidity and Mortality conference cases: effect on the occurrence of adverse events-study protocol of a cluster randomised controlled trial.
Nicolas Michel, Bernard Bui-Xuan, Lionel Bapteste, Thomas Rimmele, Marc Lilot, Hélène Favre

Trials· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia.
Shilpa Gandre-Babbe, Prasuna Paluru, Chiaka Aribeana, Stella T Chou, Silvia Bresolin, Helene Favre

Blood· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia.
Severa Bunda, Michelle W Kang, Stephanie S Sybingco, Julie Weng, Helene Favre

Cancer Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a collaborative database for epidemiological analyses and professional practice evaluation.
Evelyne Decullier, Laurent Juillard, Mathilde Bailly, Christelle Maurice, Sophie Favé, Hélène Favre

J Eval Clin Pract· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication and extension of association between common genetic variants in SIM1 and human adiposity.
Michael M Swarbrick, Daniel S Evans, Maria I Valle, Hélène Favre, Shi-Hsuan Wu

Obesity (Silver Spring)· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.
Sayali A Ranadive, Baran Ersoy, Helene Favre, Clement C Cheung, Stephen M Rosenthal

Clin Endocrinol (Oxf)· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A conserved lysine in the estrogen receptor DNA binding domain regulates ligand activation profiles at AP-1 sites, possibly by controlling interactions with a modulating repressor.
Rosalie M Uht, Paul Webb, Phuong Nguyen, Richard H Price, Cathleen Valentine, Helene Favre

Nucl Recept· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis